Surface Oncology to Participate in the 2023 Guggenheim
CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation......
Reneo Pharmaceuticals to Participate in SVB Securities
IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the......
Revolution Medicines to Participate in Upcoming Investor
REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted......
Aurora Mobile Wins 2022 Excellent Digital Service Provider
SHENZHEN, China, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer......
Biotech Acquisition Company Announces Liquidation
New York, New York, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”) (Nasdaq: BIOT), announced today that it will not......
Algoma Steel to Announce Fiscal 2023 Third Quarter Results
SAULT STE. MARIE, Ontario, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma”), a leading Canadian producer of......
NVIDIA Sets Conference Call for Fourth-Quarter Financial
CFO Commentary to Be Provided in Writing Ahead of Call......
G1 Therapeutics Announces Inducement Grants Under Nasdaq
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today......
ORIC Pharmaceuticals to Participate in Upcoming Investor
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company......
FTAI Aviation Ltd. to Participate in the Stifel 2023
PDF Version NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ:FTAI) (the “Company”) today announced that Joe Adams, Chief......